RESÚMENES OCTUBRE 2006

.

Child & Adolescent Disorders

(Haga un click en la información del journal para acceder al resúmen)

 

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study

Wasserman, Stacey; Iyengar, Rupa; Chaplin, William F; Watner, Dryden; Waldoks, Shulamit E; Anagnostou, Evdokia; Soorya, Latha; Hollander, Eric

International Clinical Psychopharmacology. 21(6):363-367, November 2006

Children with Schizophrenia: Clinical Picture and Pharmacological Treatment

Masi, Gabriele; Mucci, Maria; Pari, Cinzia

CNS Drugs. 20(10):841-866, 2006

Controlled, Blindly Rated, Direct-Interview Family Study of a Prepubertal and Early-Adolescent Bipolar I Disorder Phenotype. Morbid Risk, Age at Onset, and Comorbidity

Barbara Geller, Rebecca Tillman, Kristine Bolhofner, Betsy Zimerman, Nancy A. Strauss, Patricia Kaufmann

Arch Gen Psychiatry. 2006;63:1130-1138

 

Phenomenology of Children and Adolescents With Bipolar Spectrum Disorders

David Axelson, Boris Birmaher, Michael Strober, Mary Kay Gill, Sylvia Valeri, Laurel Chiappetta, Neal Ryan, Henrietta Leonard, Jeffrey Hunt, Satish Iyengar, Jeffrey Bridge, Martin Keller

Arch Gen Psychiatry. 2006;63:1139-1148

 

Pituitary Volume in Treatment-Naïve Pediatric Major Depressive Disorder

Frank P. MacMaster, Aileen Russell, Yousha Mirza, Matcheri S. Keshavan, S. Preeya Taormina, Rashmi Bhandari, Courtney Boyd, Michelle Lynch, Michelle Rose, Jennifer Ivey, Gregory J. Moore and David R. Rosenberg

Biological Psychiatry. Volume 60, Issue 8, 15 October 2006, Pages 862-866

 

Early childhood sleep and eating problems as predictors of adolescent and adult mood and anxiety disorders

Say How Ong, Priya Wickramaratne, Min Tang and Myrna M. Weissman

Journal of Affective Disorders. Volume 96, Issues 1-2, November 2006, Pages 1-8

 

ADHD Prescriptions Run in Families

Jim Rosack

Psychiatr News October 20, 2006. Volume 41, Number 20, page 2

Emergency Department Visits Involving ADHD Stimulant Medications

The New Dawn Report. Issue 29, 2006

 

The clinical spectrum of autism

Susan E. Folstein

Clinical Neuroscience Research. Volume 6, Issues 3-4, October 2006, Pages 113-117

Abnormalities of cortical minicolumnar organization in the prefrontal lobes of autistic patients

M.F. Casanova, I. van Kooten, A.E. Switala, H. van Engeland, H. Heinsen, H.W.M. Steinbusch, P.R. Hof and C. Schmitz

Clinical Neuroscience Research. Volume 6, Issues 3-4, October 2006, Pages 127-133

Structural MRI in autism: Findings and future directions

Matthew Mosconi, Lonnie Zwaigenbaum and Joseph Piven

Clinical Neuroscience Research. Volume 6, Issues 3-4, October 2006, Pages 135-144

 

The genetic architecture of autism and related disorders

D.E. Grice and J.D. Buxbaum

Clinical Neuroscience Research. Volume 6, Issues 3-4, October 2006, Pages 161-168

Pharmacology of autism

Christopher J. McDougle, Kimberly A. Stigler, Craig A. Erickson and David J. Posey

Clinical Neuroscience Research. Volume 6, Issues 3-4, October 2006, Pages 179-188

Cerebellar contributions to autism spectrum disorders

Greg Allen

Clinical Neuroscience Research. Volume 6, Issues 3-4, October 2006, Pages 195-207

Caudate Nucleus Volume and Cognitive Performance: Are They Related in Childhood Psychopathology?

Gerald T. Voelbel, Marsha E. Bates, Jennifer F. Buckman, Gahan Pandina and Robert L. Hendren

Biological Psychiatry. Volume 60, Issue 9, 1 November 2006, Pages 942-950

Biological Risk Factors in Pediatric Bipolar Disorder

Mani N. Pavuluri, David B. Henry, Sruti S. Nadimpalli, Megan Marlow O’Connor and John A. Sweeney

Biological Psychiatry. Volume 60, Issue 9, 1 November 2006, Pages 936-941

Prevalence, Clinical Correlates, and Longitudinal Course of Severe Mood Dysregulation in Children

Melissa A. Brotman, Mariana Schmajuk, Brendan A. Rich, Daniel P. Dickstein, Amanda E. Guyer, E. Jane Costello, Helen L. Egger, Adrian Angold, Daniel S. Pine and Ellen Leibenluft

Biological Psychiatry. Volume 60, Issue 9, 1 November 2006, Pages 991-997

A Pilot Study of Antidepressant-Induced Mania in Pediatric Bipolar Disorder: Characteristics, Risk Factors, and the Serotonin Transporter Gene

Fiona M. Baumer, Meghan Howe, Kim Gallelli, Diana Iorgova Simeonova, Joachim Hallmayer and Kiki D. Chang

Biological Psychiatry. Volume 60, Issue 9, 1 November 2006, Pages 1005-1012

Psychopathology in Young People With Intellectual Disability

Stewart L. Einfeld, Andrea M. Piccinin, Andrew Mackinnon, Scott M. Hofer, John Taffe, Kylie M. Gray, Daniel E. Bontempo, Lesa R. Hoffman, Trevor Parmenter, Bruce J. Tonge

JAMA. 2006;296:1981-1989

 

High rates of recurrence of depression in children and adolescents

Dunn V, Goodyer IM

Evidence-Based Mental Health 2006;9:95

Risperidone maintenance treatment increases time to symptom recurrence in young people with disruptive behaviour disorders

Reyes M, Buitelaar J, Toren P, et al.

Evidence-Based Mental Health 2006;9:105

Do anxiety and depression cluster into distinct groups?: a test of tripartite model predictions in a community sample of youth

Melinda F. Cannon, M.S., Carl F. Weems

Depression and Anxiety. Volume 23, Issue 8 , Pages 453 - 460

 

Neuropsychological disorders in teenagers with attention deficit hyperactivity disorder
Mulas F, Etchepareborda MC, Abad-Mas L, Diaz-Lucero A, Hernandez S, de la Osa A, Pascuale MJ, Ruiz-Andres R

Rev Neurol. 2006 Oct 10;43 Suppl 1:S71-81

 

A Prospective, Open-Label Trial of Memantine in the Treatment of Cognitive, Behavioral, and Memory Dysfunction in Pervasive Developmental Disorders

Thomas Owley, Jeff Salt, Stephen Guter, Adam Grieve, Laura Walton, Nelson Ayuyao, Bennett L. Leventhal, Edwin H. Cook Jr.

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 517 -524

 

A Double-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder

Eric Hollander, Stacey Wasserman, Erika N. Swanson, William Chaplin, Melissa L. Schapiro, Karen Zagursky, Sherie Novotny

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 541 -548

 

Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: A Blinded Discontinuation Study

Pieter W. Troost, Monika Althaus, Bertine E. Lahuis, Jan K. Buitelaar, Ruud B. Minderaa, Pieter J. Hoekstra

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 561 -573

 

Risperidone in Preschool Children with Autistic Spectrum Disorders: An Investigation of Safety and Efficacy

Joan Luby, Christine Mrakotsky, Melissa Meade Stalets, Andy Belden, Amy Heffelfinger,

Meghan Williams, Edward Spitznagel

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 575 -587

 

A Prospective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders

Lawrence Scahill, Michael G. Aman, Christopher J. McDougle, James T. McCracken, Elaine Tierney, James Dziura, L. Eugene Arnold, David Posey, Christopher Young, Bhavik Shah, Jaswinder Ghuman, Louise Ritz, Benedetto Vitiello

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 589 -598

 

Open-Label Atomoxetine for Attention-Deficit/ Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders

David J. Posey, Ryan E. Wiegand, Jennifer Wilkerson, Melissa Maynard, Kimberly A. Stigler, Christopher J. McDougle

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 599 -610

 

Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: A Pilot Study

Pieter W. Troost, Mark-Peter Steenhuis, Hanneke G. Tuynman-Qua, Luuk J. Kalverdijk, Jan K. Buitelaar, Ruud B. Minderaa, Pieter J. Hoekstra

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 611 -619

 

A Prospective, Open-Label Trial of Galantamine in Autistic Disorder

Rob Nicolson, Beth Craven-Thuss, Judy Smith

Journal of Child and Adolescent Psychopharmacology. Oct 2006, Vol. 16, No. 5 : 621 -629

.

Regresar a RESÚMENES OCTUBRE 2006